Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Rayno Life Science: Biotechnology Sector Should Find Support Today 0 comments
    Nov 9, 2012 11:05 AM | about stocks: ILMN

    Trends from early trading show promise for intermediate support in larger cap biotech shares today with the NASDAQ up 0.5% in early trading. This could be a good day for covering shorts and re-balancing in anticipation for a Q4 rally :

    The IBB (130.82) is up 1.88%. The XBI is up 2.37%.

    MO stocks are up: ALXN, MDVN, REGN,

    The Rayno Biopharma Focus stocks are all green.

    Illumina (NASDAQ:ILMN) is up 2.47%. We reiterated buy yesterday.

    Sequenom (SQNM 3.56) is big winner up 17% on their Q3 Report with Revenues up 25% over prior year.

    AAPL ($544) which coincided with the MO stock sell-off in biotech in mid-October is up 1.3%.

    Disclosure: I am long AAPL, ILMN.

    Stocks: ILMN
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.